Filing Details

Accession Number:
0001179110-17-005327
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-04-03 09:19:33
Reporting Period:
2017-03-31
Filing Date:
2017-04-03
Accepted Time:
2017-04-03 09:19:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1346830 Cara Therapeutics Inc. CARA () NY
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
943431 Joshua Ruch 152 West 57Th Street, 23Rd Floor
New York NY 10019
No No Yes No
1082907 Habib Kairouz 152 West 57Th Street, 23Rd Floor
New York NY 10019
No No Yes No
1120545 Mark Leschly 152 West 57Th Street, 23Rd Floor
New York NY 10019
No No Yes No
1325385 Rho Capital Partners Llc 152 West 57Th Street, 23Rd Floor
New York NY 10019
No No Yes No
1419636 Rho Ventures Vi Lp 152 West 57Th Street, 23Rd Floor
New York NY 10019
No No Yes No
1478944 Rmv Vi, L.l.c. 152 West 57Th Street, 23Rd Floor
New York NY 10019
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-31 500,000 $18.19 3,568,057 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Footnotes
  1. These securities are owned directly by Rho Ventures VI, L.P. ("RV VI"). RMV VI, L.L.C. ("RMV") is the general partner of RV VI and Rho Capital Partners LLC ("RCP") is the managing member of RMV. Mark Leschly, Habib Kairouz and Joshua Ruch are managing members of RCP and exercise shared voting and investment power with respect to the shares owned by RV VI. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his or its respective pecuniary interest therein.